Rosa Della Monica
Overview
Explore the profile of Rosa Della Monica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turco L, Della Monica R, Giordano P, Cuomo M, Biazzo M, Mateu B, et al.
Front Oncol
. 2024 Dec;
14:1458990.
PMID: 39634265
Oncotherapy can shape intestinal microbiota, which, in turn, may influence therapy effectiveness. Furthermore, microbiome signatures during treatments can be leveraged for the development of personalised therapeutic protocols in cancer treatment...
2.
Abate M, Porru M, Campani V, Leonetti C, Nele V, Di Paola R, et al.
J Control Release
. 2024 Nov;
377:458-469.
PMID: 39577464
Glioblastoma (GBM) is a highly aggressive brain cancer with poor clinical outcome. Unfortunately, chemotherapy with temozolomide (TMZ) has a limited efficacy due to resistance mainly attributed to O6-methylguanine methyl transferase...
3.
Franca R, Di Crescenzo R, Ugga L, Della Monica R, DAvella E
Int J Surg Pathol
. 2024 Nov;
:10668969241295689.
PMID: 39563513
Malignant melanotic nerve sheath tumor (MMNST) represents a highly aggressive neoplasm arising both in peripheral and cranial nerves. It accounts for < 1% of all nerve sheath tumors, but the...
4.
Hench J, Hultschig C, Brugger J, Mariani L, Guzman R, Soleman J, et al.
Acta Neuropathol Commun
. 2024 Apr;
12(1):51.
PMID: 38576030
DNA methylation analysis based on supervised machine learning algorithms with static reference data, allowing diagnostic tumour typing with unprecedented precision, has quickly become a new standard of care. Whereas genome-wide...
5.
Cuomo M, Coretti L, Costabile D, Della Monica R, De Riso G, Buonaiuto M, et al.
Sci Rep
. 2023 Oct;
13(1):18197.
PMID: 37875530
The gut-brain axis involves several bidirectional pathway communications including microbiome, bacterial metabolites, neurotransmitters as well as immune system and is perturbed both in brain and in gastrointestinal disorders. Consistently, microbiota-gut-brain...
6.
Della Monica R, Buonaiuto M, Cuomo M, Pagano C, Trio F, Costabile D, et al.
Cell Death Dis
. 2023 Sep;
14(9):638.
PMID: 37758718
Despite intense research efforts, glioblastoma remains an incurable brain tumor with a dismal median survival time of 15 months. Thus, identifying new therapeutic targets is an urgent need. Here, we...
7.
Corvino S, Del Basso De Caro M, Franca R, Corazzelli G, Della Monica R, Chiariotti L, et al.
World Neurosurg
. 2023 Sep;
179:e404-e415.
PMID: 37659753
Background: Atypical teratoid/rhabdoid tumor (AT/RT) of the nervous system is a rare and highly malignant neoplasm, mainly affecting children, first recognized as a pathologic entity in 1996 and added to...
8.
Franca R, Ugga L, Della Monica R, Corvino S
Pathol Res Pract
. 2023 Jul;
248:154698.
PMID: 37499517
The latest WHO Classification of tumours of the Central Nervous System (CNS) emphasizes the necessity of an integrated diagnostic approach during the workup of a CNS neoplasm. In addition to...
9.
Cannella L, Della Monica R, Marretta A, Iervolino D, Vincenzi B, De Chiara A, et al.
Cells
. 2023 Jun;
12(12).
PMID: 37371106
Dacarbazine is an important drug in the therapeutic landscape of leiomyosarcoma (LMS). Alkylating agents are subjected to resistance mechanisms based on anti-apoptotic pathways and repair mechanisms, including the DNA repair...
10.
A Rare Adult Primary Intracranial Sarcoma, -Mutant Identified by Epigenomic Profiling: A Case Report
Marinelli A, Cuomo M, Franca R, Buonaiuto M, Costabile D, Pagano C, et al.
Brain Sci
. 2023 Feb;
13(2).
PMID: 36831778
Diagnoses of primary malignant mesenchymal brain tumors are a challenge for pathologists. Here, we report the case of a 52-year-old man with a primary brain tumor, histologically diagnosed as a...